Does BORTEZOMIB Cause Injection site erythema? 301 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 301 reports of Injection site erythema have been filed in association with BORTEZOMIB (bortezomib). This represents 0.6% of all adverse event reports for BORTEZOMIB.
301
Reports of Injection site erythema with BORTEZOMIB
0.6%
of all BORTEZOMIB reports
1
Deaths
23
Hospitalizations
How Dangerous Is Injection site erythema From BORTEZOMIB?
Of the 301 reports, 1 (0.3%) resulted in death, 23 (7.6%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Injection site erythema Listed in the Official Label?
Yes, Injection site erythema is listed as a known adverse reaction in the official FDA drug label for BORTEZOMIB.
What Other Side Effects Does BORTEZOMIB Cause?
Plasma cell myeloma (6,683)
Off label use (4,754)
Neuropathy peripheral (4,067)
Drug ineffective (2,730)
Diarrhoea (2,244)
Thrombocytopenia (2,082)
Death (2,025)
Pneumonia (2,020)
Fatigue (1,757)
Neutropenia (1,530)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which BORTEZOMIB Alternatives Have Lower Injection site erythema Risk?
BORTEZOMIB vs BOSENTAN
BORTEZOMIB vs BOSENTAN\BOSENTAN
BORTEZOMIB vs BOSULIF
BORTEZOMIB vs BOSUTINIB
BORTEZOMIB vs BOTOX